Eurofins Scient (OTCMKTS:ERFSF) Shares Gap Down – Here’s What Happened

Shares of Eurofins Scient (OTCMKTS:ERFSFGet Free Report) gapped down before the market opened on Wednesday . The stock had previously closed at $73.7820, but opened at $71.2280. Eurofins Scient shares last traded at $73.8648, with a volume of 201 shares trading hands.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on ERFSF. Citigroup reiterated a “neutral” rating on shares of Eurofins Scient in a report on Wednesday, October 22nd. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating on shares of Eurofins Scient in a research note on Wednesday, October 29th. One equities research analyst has rated the stock with a Strong Buy rating and six have assigned a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold”.

Check Out Our Latest Stock Report on Eurofins Scient

Eurofins Scient Stock Performance

The business has a 50 day simple moving average of $69.96 and a two-hundred day simple moving average of $72.77. The company has a quick ratio of 1.19, a current ratio of 1.26 and a debt-to-equity ratio of 0.77.

Eurofins Scient Company Profile

(Get Free Report)

Eurofins Scientific is a global provider of bioanalytical testing and laboratory services, offering a wide array of testing solutions to pharmaceutical, food, environmental, agriscience and consumer products industries. Its core services include pharmaceutical quality control, environmental testing for water and air quality, food safety analysis, agrochemical trials and clinical diagnostic support. The company operates specialized laboratories equipped with advanced analytical technologies such as chromatography, mass spectrometry and molecular biology to ensure compliance with regulatory standards and to support research and development efforts across multiple sectors.

Founded in 1987 by Gilles Martin and headquartered in Luxembourg, Eurofins has grown through a combination of organic expansion and strategic acquisitions.

See Also

Receive News & Ratings for Eurofins Scient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eurofins Scient and related companies with MarketBeat.com's FREE daily email newsletter.